A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are either combined in ready form or mixed before administration. Safety, efficacy, and immunogenicity of a combined immunizing agent are high.
The increase in pediatric population is one of the primary growth factors for this market. With the increase in pediatric population, the demand for combination vaccines for immunization is higher as newborn infants are more vulnerable to various infectious diseases due to weak immune systems. These vaccines help reduce the number of shots and healthcare center visits, which consequently save time and money. It has been observed that the occurrence of viral infections and diseases such as polio, tetanus, diphtheria, smallpox, chickenpox, and measles is high among children in developing nations.
The Americas is expected to be the major revenue contributor to the market by 2023. The introduction of strict regulatory norms that recommend proper vaccination of infants and the continuous efforts by vendors and national organizations to promote the use of human combination vaccines, will drive the market’s growth prospects in the Americas.
The global Human Combination Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Combination Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Human Combination Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Combination Vaccines in these regions.
This research report categorizes the global Human Combination Vaccines market by top players/brands, region, type and end user. This report also studies the global Human Combination Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Serum Institute of India
Market size by Product
Human Combination Inactivated Vaccines
Human Combination Live Attenuated Vaccines
Market size by End User
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Human Combination Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Human Combination Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Combination Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Human Combination Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Human Combination Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Combination Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.